Skip to main content

Reactive oxygen species and nitric oxide in viral diseases

Biological Trace Element Research volume 56, pages 107–116 (1997)Cite this article

Abstract

Metabolites derived from superoxide (o2 •−) and nitric oxide (NO•) play an important role in antimicrobial and antitumoral defense, but may also harm the host. Low levels of such metabolites can also facilitate viral replication because of their mitogenic effects on cells. Most viruses grow better in proliferating cells, and indeed, many viruses induced in their host cell changes similar to those seen early after treatment with mitogenic lectins. Influenza and paramyxoviruses activate in phagocytes the generation of superoxide by a mechanism involving the interaction between the viral surface glycoproteins and the phagocyte’s plasma membrane. Interestingly, viruses that activate this host defense mechanism are toxic when injected in the bloodstream of animals. Mice infected with influenza virus undergo oxidative stress. In addition, a wide array of cytokines are formed in the lung, contributing to the systemic effects of influenza. Oxidative stress is seen also in chronic viral infections, such as AIDS and viral hepatitis. Oxidant production in viral hepatitis may contribute to the emergence of hepatocellular carcinoma, a tumor seen in patients after years of chronic inflammation of the liver. Antioxidants and agents that downregulate proinflammatory cytokines and lipid mediators may be a useful complement to specific antiviral drugs in the therapy of viral diseases.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. D. S. Bredt, and S. H. Snyder, Nitric oxide: a physiologic messenger molecule,Annu. Rev. Biochem. 63, 175–195 (1994).

    PubMed  Article  CAS  Google Scholar 

  2. J. L. Zweier, P. Wang, A. Samouilov, and P. Kuppusamy, Enzyme-independent formation of nitric oxide in biological tissues (see comments),Nature Med. 1, 804–809 (1995).

    PubMed  Article  CAS  Google Scholar 

  3. V. Darley-Usmar, H. Wiseman, and B. Halliwell, Nitric oxide and oxygen radicals: a question of balance,FEBS Lett. 369, 131–135 (1995).

    PubMed  Article  CAS  Google Scholar 

  4. B. Halliwell, J. M. C. Gutteridge, and C. E. Cross, Free radicals, antioxidants, and human disease—where are we now,J. Lab. Clin. Med. 119, 598–620 (1992).

    PubMed  CAS  Google Scholar 

  5. R. H. Burdon, Superoxide and hydrogen peroxide in relation to mammalian cell proliferation.Free Radical Biol. Med. 18, 775–794 (1995).

    Article  CAS  Google Scholar 

  6. M. E. Belding, S. J. Klebanoff, and C. G. Ray, Peroxidase-Mediated virucidal systems,Science 167, 195–196 (1970).

    PubMed  Article  CAS  Google Scholar 

  7. E. F. Wheelock, and S. T. Toy, Participation of lymphocytes in viral infections,Adv. Immunol. 16, 123–184 (1973).

    PubMed  CAS  Google Scholar 

  8. J. F. Woodruff, and J. J. Woodruff, T lymphocyte interaction with viruses and virusinfected tissues,Prog. Med. Virol. 19, 120–160 (1975).

    PubMed  CAS  Google Scholar 

  9. G. M. Butchko, R. B. Armstrong, W. J. Martin, and F. A. Ennis, Influenza A viruses of the H2N2 subtype are lymphocyte mitogens,Nature 271, 65–67 (1978).

    Article  Google Scholar 

  10. E. Peterhans, E. Haenggeli, P. Wild, and R. Wyler, Mitochondrial calcium uptake during infection of chicken embryo fibroblasts with Semliki Forest virus,J. Virol. 29, 143–152 (1979).

    PubMed  CAS  Google Scholar 

  11. E. Peterhans, Sendai virus stimulates chemiluminescence in mouse spleen cells,Biochem. Biophys. Res. Commun. 91, 383–392 (1979).

    PubMed  Article  CAS  Google Scholar 

  12. E. Peterhans, Chemiluminescence: an early event in the interaction of Sendai and influenza viruses with mouse spleen cells. I. The role of the envelope glycoproteins in the stimulation of chemiluminescence,Virology 105, 445–455 (1980).

    PubMed  Article  CAS  Google Scholar 

  13. W. Henle, and G. Henle, The toxicity of influenza virus,Science 102, 398–400 (1945).

    PubMed  Article  Google Scholar 

  14. I. L. Bennet, R. R. Wagner, and V. S. Lequire, Pyrogenicity of influenza virus in rabbits,Proc. Soc. Exp. Biol. Med. 71, 132–133 (1949).

    Google Scholar 

  15. J. M. Edney, Studies on the toxicity of influenza viruses, PhD thesis, University of London (1955).

  16. E. Peterhans, F. Mettler, and E. Manser, The effect of virus particle size on chemiluminescence induction by influenza and Sendai-viruses in mouse spleen cells,Free Radical Res. Commun. 11, 11–22 (1990).

    Article  CAS  Google Scholar 

  17. E. Peterhans, M. Grob, T. Bürge, and R. Zanoni, Virus-induced formation of reactive oxygen intermediates in phagocytic cells,Free Radical Res. Commun. 3, 39–46 (1987).

    Article  CAS  Google Scholar 

  18. E. Peterhans, T. W. Jungi, and R. Stocker, Autotoxicity and reactive oxygen in viral disease, inOxy-Radicals in Molecular Biology and Pathology, UCLA Symposia on Molecular and Cellular Biology, New Series, vol. 82, P. A. Cerutti, I. Fridovich, and J. M. McCord, eds., pp. 543–562 (1988).

  19. G. D. Buffinton, S. Christen, E. Peterhans, and R. Stocker, Oxidative stress in lungs of mice infected with influenza A virus,Free Radical Res. Commun. 16, 99–110 (1992).

    Article  CAS  Google Scholar 

  20. T. Hennet, E. Peterhans, and R. Stocker, Alterations in antioxidant defences in lung and liver of mice infected with influenza A virus,J. Gen. Virol. 73, 39–46 (1992).

    PubMed  CAS  Google Scholar 

  21. T. Oda, T. Akaike, T. Hamamoto, F. Suzuki, T. Hirano, and H. Maeda, Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymerconjugated SOD,Science 244, 974–976 (1989).

    PubMed  Article  CAS  Google Scholar 

  22. P. S. Morahan, A. Pinto, D. Stewart, D. M. Murasko, and M. A. Brinton, Varying role of alpha/beta interferon in the antiviral efficacy of synthetic immunomodulators against Semliki Forest virus infection,Antiviral Res. 15, 241–254 (1991).

    PubMed  Article  CAS  Google Scholar 

  23. S. C. Kunder, L. Wu, and P. S. Morahan, Protection against murine cytomegalovirus infection in aged mice and mice with severe combined immunodeficiency disease with the biological response modifiers polyribosinic-polycytidylic acid stabilized withl-lysine and carboxymethylcellulose, maleic anhydride divinyl ether and colony stimulating factor 1,Antiviral Res. 21, 233–245 (1993).

    PubMed  Article  CAS  Google Scholar 

  24. N. O. Bykova, N. V. Gorbunov, A. A. Bolgarev, M. V. Savina, T. I. Ivanova, M. A. Egoiants, V. F. Vanin, and M. P. Prozorovskaia, Oxidative phosphorylation in liver mitochondria in toxic form of experimental form of influenza,Biull. Eksp. Biol. Med. 112, 617–619 (1991).

    PubMed  CAS  Google Scholar 

  25. T. Akaike, Y. Noguchi, S. Ijiri, K. Setoguchi, M. Suga, Y. M. Zheng, B. Dietzschold, and H. Maeda, Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals,Proc. Natl. Acad. Sci. USA 93, 2448–2453 (1996).

    PubMed  Article  CAS  Google Scholar 

  26. K. G. Nicholson, Clinical features of Influenza,Semin. Respir. Infect. 7, 26–37 (1992).

    PubMed  CAS  Google Scholar 

  27. S. Ansher, W. Thompson, and W. Habig, Vaccine-induced alterations in hepatic drug metabolism,Vaccine 9, 277–283 (1991).

    PubMed  Article  CAS  Google Scholar 

  28. T. Hennet, H. J. Ziltener, K. Frei, and E. Peterhans, A kinetic study of immune mediators in the lungs of mice infected with iinfluenza-A virus,J. Immunol. 149, 932–939 (1992).

    PubMed  CAS  Google Scholar 

  29. I. Dvoretzky, Flulike symptoms with interferon,J. Am. Acad. Dermatol. 22, 321–322 (1990).

    PubMed  CAS  Article  Google Scholar 

  30. S. J. Klebanoff, and R. W. Coombs, Viricidal effect of polymorphonuclear leukocytes on human immunodeficiency virus-1—role of the myeloperoxidase system.J. Clin. Invest. 89, 2014–2017 (1992).

    PubMed  CAS  Google Scholar 

  31. R. Rott, H. D. Klenk, Y. Nagai, and M. Tashiro, Influenza viruses, cell enzymes, and pathogenicity,Am J. Respir. Crit. Care Med. 152 4 Suppl., S16-S19 (1995).

    PubMed  CAS  Google Scholar 

  32. H. Kido, K. Sakai, Y. Kishino, and M. Tashiro, Pulmonary surfactant is a potential endogenous infibitor of proteolytic activation of Sendai and influenza a virus,FEBS Lett. 322, 115–119 (1993).

    PubMed  Article  CAS  Google Scholar 

  33. K. McCusker, Mechanisms of respiratory tissue injury from cigarette smoking,Am. J. Med. 93 (1A), 18S-21S (1992).

    PubMed  Article  CAS  Google Scholar 

  34. F. L. Ruben, and T. R. Cate, Influenza pneumonia,Semin. Respir. Infect. 2, 122–129 (1987).

    PubMed  CAS  Google Scholar 

  35. W. Dröge, H. P. Eck, and S. Mihm, Oxidant-antioxidant status in human immunodeficiency virus infection,Oxygen radicals in biological systems, Methods Enzymol. 233, 594–601 (1994).

    Article  Google Scholar 

  36. D. J. Malvy, M. J. Richard, J. Arnaud, A. Favier, and O. Amedee, Manesme, relationship of plasma malondialdehyde, vitamin E and antioxidant micronutrients to human immunodeficiency virus-1 seropositivity,Clin. Chim. Acta 224, 89–94 (1994).

    PubMed  Article  CAS  Google Scholar 

  37. J. Fuchs, I. Emerit, A. Levy, L. Cernajvski, H. Schofer, and R. Milbradt, Clastogenic factors in plasma of HIV-1 infected patients,Free Radical Biol. Med. 19, 843–848 (1995).

    Article  CAS  Google Scholar 

  38. J. Piette, and S. Legrand Poels, HIV-1 reactivation after an oxidative stress mediated by different reactive oxygen species,Chem. Biol. Interact. 91, 79–89 (1994).

    PubMed  Article  CAS  Google Scholar 

  39. B. Piret, S. Legrand Poels, C. Sappey, and J. Piette, NF-Kappa B transcription factor and human immunodeficiency virus type 1 (HIV-1) activation by methylene blue photosensitization.Eur. J. Biochem. 228, 447–455 (1995).

    PubMed  Article  CAS  Google Scholar 

  40. R. Schreck, P. Rieber, and P. A. Baeuerle, Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-Kappa-B transcription factor and HIV-1,EMBO J. 10, 2247–2258 (1991).

    PubMed  CAS  Google Scholar 

  41. T. Hennet, C. Richter, and E. Peterhans, Tumour necrosis factor-alpha induces superoxide anion generation in mitochondria of L929 cells,Biochem. J. 289, 587–592 (1993).

    PubMed  CAS  Google Scholar 

  42. V. B. O’Donnell, S. Spycher, and A. Azzi, Involvement of oxidants and oxidant-generating enzyme(s) in tumour-necrosis-factor-alpha-mediated apoptosis: role for lipoxygenase pathway but not mitochondrial respiratory chain,Biochem. J. 310, 133–141 (1995).

    PubMed  CAS  Google Scholar 

  43. D. Pietraforte, E. Tritarelli, U. Testa, and M. Minetti, Gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages.J. Leukocyte Biol. 55, 175–182 (1994).

    PubMed  CAS  Google Scholar 

  44. M. O. Westendorp, V. A. Shatrov, K. Schulze Osthoff, R. Frank, M. Kraft, M. Los, P. H. Krammer, W. Droge, and V. Lehmann, HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state,Embo J. 14, 546–554 (1995).

    PubMed  CAS  Google Scholar 

  45. S. Arai, T. Munakata, and K. Kuwano, Mycoplasma interaction with lymphocytes and phagocytes: role of hydrogen peroxide released from M. pneumoniae,Yale J. Biol. Med. 56, 631–638 (1983).

    PubMed  CAS  Google Scholar 

  46. P. Köppel, E. Peterhans, G. Bertoni, R. Keist, P. Groscurth, R. Wyler, and R. Keller, Induction of chemiluminescence during interaction of tumoricidal effector cell populations and tumor cells is dependent on the presence of mycoplasma,J. Immunol. 132, 2021–2029 (1984).

    PubMed  Google Scholar 

  47. J. Chochola, A. D. Strosberg, and M. Stanislawski, Release of hydrogen peroxide from human T cell lines and normal lymphocytes co-infected with HIV-1 and mycoplasma,Free Radical Res. 23, 197–212 (1995).

    Article  CAS  Google Scholar 

  48. G. W. Pace, and C. D. Leaf, The role of oxidative stress in HIV disease,Free Radical Biol. Med. 19, 523–528 (1995).

    Article  CAS  Google Scholar 

  49. M. L. Linial, and M. Emerman, RNA tumor virus update,Cancer Cells—A Monthly Rev. 3, 351–354 (1991).

    CAS  Google Scholar 

  50. K. H. Vousden, and P. J. Farrell, Viruses and human Cancer,Br. Med. Bull. 50, 560–581 (1994).

    PubMed  CAS  Google Scholar 

  51. Anonymus. The A to F of viral hepatitis,Lancet 336, 1158–1160 (1990).

  52. A. J. Zuckerman, The new GB hepatitis viruses,Lancet 345, 1453–1454 (1995).

    PubMed  Article  CAS  Google Scholar 

  53. D. R. Milich, J. Jones, J. Hughes, and T. Maruyama, Hepatitis B virus infection, the immune response and hepatocellular carcinoma,Ciba Found. Symp. 187, 113–129 (1994).

    PubMed  CAS  Google Scholar 

  54. H. Ohshima, and H. Bartsch, Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis,Mutat. Res. 305, 253–264 (1994).

    PubMed  CAS  Google Scholar 

  55. B. N. Ames, L. S. Gold, and W. C. Willett, The causes and prevention of cancer,Proc. Natl. Acad. Sci. USA 92, 5258–5265 (1995).

    PubMed  Article  CAS  Google Scholar 

  56. R. Rott, S. Herzog, B. Fleischer, A. Winokur, J. Amsterdam, W. Dyson, and H. Koprowski, Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders,Science 228, 755–756 (1985).

    PubMed  Article  CAS  Google Scholar 

  57. M. Z. Yong, M. K. H. Schafer, E. Weihe, S. Hai, S. Corisdeo, F. F. Zhen, H. Koprowski, and B. Dietzschold, Severity of neurological signs and degree of inflammatory lesions in the brains of rats with Borna disease correlate with the induction of nitric oxide synthase,J. Virol. 67, 5786–5791 (1993).

    Google Scholar 

  58. D. C. Hooper, S. T. Ohnishi, R. Kean, Y. Numagami, B. Dietzschold, and H. Koprowski, Local nitric oxide production in viral and autoimmune diseases of the central vernous system,Proc. Natl. Acad. Sci. USA 92, 5312–5316 (1995).

    PubMed  Article  CAS  Google Scholar 

  59. I. L. Campbell, A. Samimi, and C. S. Chiang, Expression of the inducible nitric oxide synthase. Correlation with neuropathology and clinical features in mice with lymphocytic choriomeningitis,J. Immunol. 153, 3622–3629 (1994).

    PubMed  CAS  Google Scholar 

  60. V. L. Dawson, and T. M. Dawson, Free radicals and neuronal cell death,Cell Death Differ. 3, 71–78 (1996).

    PubMed  CAS  Google Scholar 

  61. E. A. Butz, B. S. Hostager, and P. J. Southern, Macrophages in mice acutely infected with lymphocytic choriomeningitis virus are primed for nitric oxide synthesis,Microb. Pathog. 16, 283–295 (1994).

    PubMed  Article  CAS  Google Scholar 

  62. H. Adler, B. Frech, P. Meier, T. W. Jungi, and E. Peterhans, Noncytopathic strains of bovine viral diarrhea virus prime bovine bone marrow-derived macrophages for enhanced generation of nitric oxide,Biochem. Biophys. Res. Commun. 202, 1562–1568 (1994).

    PubMed  Article  CAS  Google Scholar 

  63. M. I. Bukrinsky, H. S. Nottet, H. Schmidtmayerova, L. Dubrovsky, C. R. Flanagan, M. E. Mullins, S. A. Lipton, and H. E. Gendelman, Regulation of nitric oxide synthase activity in human immunodeficiency virus Type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease,J. Expl. Med. 181, 735–745 (1995).

    Article  CAS  Google Scholar 

  64. V. L. Dawson, T. M. Dawson, G. R. Uhl, and S. H. Snyder, Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures,Proc. Natl. Acad. Sci. USA 90, 3256–3259 (1993).

    PubMed  Article  CAS  Google Scholar 

  65. M. G. Hayman, Arbuthnott, G. Harkiss, H. Brace, P. Filippi, V. Philippon, D. Thomson, R. Vigne, and A. Wright, Neurotoxicity of peptide analogues of the transactivating protein Tat from Maedi-Visna virus and human immunodeficiency virus,Neuroscience 53, 1–6 (1993).

    PubMed  Article  CAS  Google Scholar 

  66. V. Philippon, C. Vellutini, D. Gambarelli, G. Harkiss, G. Arbuthnott, D. Metzger, R. Roubin, and P. Filippi, The basic domain of the Lentiviral Tat protein is responsible for damages in mouse brain: involvement of cytokines,Virology 205, 519–529 (1994).

    PubMed  Article  CAS  Google Scholar 

  67. K. D. Croen, Evidence for antiviral effect of nitric oxide, inhibition of herpes simplex virus type 1 replication,J. Clin. Invest. 91, 2446–2452 (1993).

    PubMed  CAS  Google Scholar 

  68. J. B. Mannick, The antiviral role of nitric oxide,Res. Immunol. 146, 693–697 (1995).

    PubMed  Article  CAS  Google Scholar 

  69. G. Karupiah, Q. W. Xie, R. M. L. Buller, C. Nathan, C. Duarte, and J. D. Macmicking, inhibition of viral replication by interferon-gamma induced nitric oxide synthase,Science 261, 1445–1448 (1993).

    PubMed  Article  CAS  Google Scholar 

  70. K. Akarid, M. Sinet, B. Desforges, and M. A. Gougerot Pocidalo, Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo.J. Virol. 69, 7001–7005 (1995).

    PubMed  CAS  Google Scholar 

  71. Z. B. Bi, and C. S. Reiss, Inhibition of vesicular stomatitis virus infection by nitric oxide.J. Virol. 69, 2208–2213 (1995).

    PubMed  CAS  Google Scholar 

  72. M. A. Beck, P. C. Kolbeck, L. H. Rohr, Q. Shi, V. C. Morris, and O. A. Levander, Vitamin E deficiency intensifies the myocardial injury of Coxsackievirus B3 infection of mice,J. Nutr. 124, 345–358 (1994).

    PubMed  CAS  Google Scholar 

  73. M. A. Beck, P. C. Kolbeck, L. H. Rohr, Q. Shi, V. C. Morris, and O. A. Levander, Benign Human Enterovirus Becomes Virulent in Selenium-Deficient Mice,J. Med. Virol. 43, 166–170 (1994).

    PubMed  Article  CAS  Google Scholar 

  74. M. A. Beck, Q. Shi, V. C. Morris, and O. A. Levander, Rapid genomic evolution of a non-virulent Coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates,Nature Med. 1, 433–436 (1995).

    PubMed  Article  CAS  Google Scholar 

  75. M. Brugh, Jr., Butylated hydroxytoluene protects chickens exposed to Newcastle disease virus,Science 197, 1291–1292 (1977).

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. Institute of Veterinary Virology, University of Berne, CH-3012, Berne, Switzerland

    Ernst Peterhans

Authors
  1. Ernst Peterhans
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ernst Peterhans.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Peterhans, E. Reactive oxygen species and nitric oxide in viral diseases. Biol Trace Elem Res 56, 107–116 (1997). https://doi.org/10.1007/BF02778986

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02778986

Index Entries

  • Virus
  • influenza
  • HIV
  • hepatitis
  • therapy
  • cytokines
  • antioxidants
  • nitric oxide
  • physiology
  • metabolism